Article Details
Retrieved on: 2021-08-19 15:45:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
That's high talk for little Apellis, which is going toe-to-toe with industry heavyweights like Alexion's Soliris and its follow-up Ultomiris with ...
Article found on: www.fiercepharma.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here